Article

Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients

2021-02-23

Abstract excerpt

<h4>Background: </h4> Coronavirus disease 2019 (COVID-19) has been associated with cutaneous findings, some being the result of drug hypersensitivity reactions such as maculopapular drug rashes (MDR). The aim of this study was to investigate whether COVID-19 is associated with the development of the MDR. Method Blood and skin samples from COVID-19 patients suffering from maculopapular drug rashes (COVID-MDR), heal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 252197b9-c6e6-5bba-bed8-3e91f2638550
DOI: 10.22541/au.161408622.22453644/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patientsDOI 10.22541/au.161408622.22453644/v1Read

Generalized Rash in Severe Hospitalized COVID Patients: Correlation between Histological Examination, Drug Intake, Blood Interleukins Profileand Long-Term Follow-UpSemantic proximity Read

Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology.Semantic proximity Read

HIV as a Host Susceptibility State for Severe Drug Hypersensitivity: Disentangling Biological Susceptibility from Drug Exposure in the FAERS DatabaseSemantic proximity Read

Immune Characteristics and HLA Associations of SARS-Cov-2 Vaccines-induced Delayed-Type Cutaneous Adverse ReactionsSemantic proximity Read

PLEOMORPHIC SKIN ERUPTIONS IN A COVID-19 AFFECTED PATIENT: CASE REPORT AND REVIEW OF THE LITERATURESemantic proximity Read

Ex vivo diagnostics using varied cellular inputs in drug-induced severe cutaneous adverse reactionsSemantic proximity Read

Demographics, Overlap, and Latency of Severe Cutaneous Adverse Reactions in an FDA DatabaseSemantic proximity Read

Molecular diagnosis of causality in T cell mediated severe cutaneous adverse drug reactionsSemantic proximity Read

COVID-19 may present with an itchy erythematous papular rash: a case reportSemantic proximity Read

Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.Semantic proximity Read

Epidemiology, clinical presentation and management of COVID-19 associated Mucormycosis: A single center experience from Pune, Western IndiaSemantic proximity Read

Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: Facial edema aligns to the severe phenotype.Semantic proximity Read